Feeling Winded After Your Workout? Long COVID May Claim Another Symptom
A new study points to another persistent effect of COVID-19, identified months after infection: reduced exercise capacity.
University of California San Francisco
Give to UCSF
Displaying 1051 - 1080 of 16507
-
-
What Does Bipolar Disorder Feel Like?
-
Voters Agree on Need for More Protections from Chemicals
A national online survey revealed American voters overwhelmingly say they want government and industry to ensure the products they buy are free of harmful chemicals, and they are willing to pay more for it.
-
At Least 66 Clinics in 15 States Have Stopped Providing Abortions Since Dobbs, Analysis Finds
-
Fall Allergies Are Real. And They’re Getting Worse.
-
UCSF Hosts First Lady Jill Biden to Discuss Breast Cancer Research
First Lady Jill Biden, Ed.D, met with top UCSF cancer leaders during a visit Friday, October 7th, to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot.
-
Back to School 2022
UCSF's back-to-school season marked a joyous return to in-person celebrations for the first time since 2019.
-
The Power of Paxlovid
-
Single-Celled Organism Uses Internal ‘Computer’ to Walk
The single-celled protozoan Euplotes eurystomus achieves a scurrying walk by coordinate its microscopic uses a simple, mechanical computer instead of a brain like most animals, UCSF researchers found.
-
Rural Seniors Reap Health Benefits From What UCSF First-Gen Nursing Program Sows
The UCSF School of Nursing is partnering with Hartnell College to prepare first-generation-to-college students to become nurses, equipped with the skills to advance health care for residents in the underserved Salinas Valley.
-
Curci Scholarship Will Boost Graduate Student Diversity
With generous support from the Shurl and Kay Curci Foundation, UCSF has begun a new scholarship for women and international scholars that promises to help build a more diverse pipeline of basic science PhD students.
-
Omicron’s Evolution and the New Bivalent COVID-19 Booster
Last month new “bivalent” booster vaccines made by Moderna and Pfizer became available that protect against currently circulating Omicron variants as well as earlier strains of the SARS-CoV-2 virus that causes COVID-19. This Q&A features Joel Ernst, MD, a UCSF professor of medicine whose research aims to understand how pathogens evade the immune system.
-
Minority Patients Less Likely to Get Newer Alzheimer’s Meds
-
Study Casts Doubt on Routine Use of Anesthesiologists in Cataract Surgery
Ophthalmologists may be able to safely cut back on having anesthesiologists or nurse anesthetists routinely at bedside during cataract surgery, which accounts for more than two million surgeries per year in the U.S., according to a new study.
-
Video Games Offer the Potential of “Experiential Medicine”
After a decade of work, scientists at UCSF’s Neuroscape Center have developed a suite of video game interventions that improve key aspects of cognition in aging adults.
-
Fewer Asian, Black, Hispanic Patients Eligible for Drugs That May Delay Alzheimer’s Progression
A new study shows that fewer Black, Hispanic and Asian patients would qualify for these treatments that may slow Alzheimer’s progression, since cognitive impairment in these groups is more likely to be caused by other forms of dementia that may be unrelated to amyloid plaques.
-
Non-Opioid Compounds Squelch Pain Without Sedation
A newly identified set of molecules alleviated pain in mice while avoiding the sedating affect that limits the use of opiates, according to a new study led by researchers at UC San Francisco.
-
UCSF Researchers Discover How Vascular Cells Develop in Prenatal Brain
UCSF has revealed how blood vessel cells develop in the prenatal human brain, paving the way to fully understand the role of these cells in healthy brain development and disease.
-
Cellular Whodunnit Nabs Top Prize at 2022 Postdoc Slam
UCSF postdoc Elise Marsan, PhD, took first place for her cell-scale crime story, “Who Killed the Neurons?” at UCSF’s 5th Annual Postdoc Slam competition.
-
A Drug Based on LSD Appears to Treat Depression in Mice Without the Psychedelic Trip
-
Why It’s Important to Know if You Have Dense Breasts
-
Cardiovascular Health Technology to Be Fast-Tracked through Innovative Fellowship Program
The new UCSF Rosenman Institute BUILD™ Heart Health program is designed as an 11-month cycle of fully funded fellowships aimed at training the next generation of health technology entrepreneurs.
-
LSD-Like Molecules Counter Depression Without the Trip
Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations. A single dose produced powerful antidepressant and antianxiety effects in mice that lasted up to two weeks.
-
Longevity Calculator Could Aid Planning After Dementia Diagnosis
-
Distinguished Clinical Researcher to Lead UCSF Interventional Cardiology Program
UCSF Health’s Heart and Vascular Center is welcoming Sammy Elmariah, MD, MPH, FACC, FAHA, FSCAI, as chief of its division of Interventional Cardiology and medical director of the division’s cardiac catheterization lab. Elmariah is a recognized expert in structural heart disease interventions and catheter-based valve therapies.
-
Parnassus Research and Academic Building Design and Site Improvements Move Forward
UCSF’s plans to build a new state-of-the-art research and academic building and rejuvenate the Parnassus Heights campus continues to build momentum.
-
Life Expectancy Tool May Improve Quality of Life for Patients With Dementia
A mortality prediction model for older adults with dementia may help physicians determine which treatments to provide while facilitating decision-making for patients and their families.
-
Surgeons Often Take a Fifth of the Lungs to Remove a Small Tumor. There May Be a Better Way
-
UCSF Statement on Improving the Equitable Distribution of MPX Vaccines
We are writing to update you on what UCSF is doing to ensure the equitable distribution of MPX vaccines in the face of ongoing vaccine shortages.
-
Landmark Study of Biomarker Data May Enable Better Treatment for Early Onset Dementia
UCSF researchers Adam Staffaroni, PhD, and Adam Boxer, MD, PhD developed models of clinical and biomarker dynamics to determine the temporal sequence of biomarker and clinical changes in f-FTD before disease progression begins.
